ASCO® GI 2024 Insights: "Clinical Validation of Northstar Response, a Novel Methylated ctDNA Therapy Response Monitoring Assay in Patients With Advanced GI Cancer Undergoing Active Treatment"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ASCO® GI 2024 Insights: "Clinical Validation of Northstar Response, a Novel Methylated ctDNA Therapy Response Monitoring Assay in Patients With Advanced GI Cancer Undergoing Active Treatment"

By Insights from 2024 ASCO® GI Annual Meeting FEATURING Ilyas Sahin

0 views

February 5, 2024

Comments 0

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

Feat. N. Robertson

32:36

Ibrahim Sahin

Early-Onset CRC: A New Epidemic With Knowns and Unknowns

39:40

Ibrahim Sahin

Young Onset Colorectal Cancer: A New Epidemic?

19:39

Vanderbilt University Medical Center (VUMC)

Helicobacter Pylori: A Bacterium That Causes Gastric Cancer

Feat. R. Peek

46:37

Albert Einstein College of Medicine

Screening for Pancreatic Cancer

Feat. A. L. Lucas

19:48

Florida Gastroenterologic Society

Colon Polyp with Carcinoma In-Situ, Intramucosal Cancer or Invasive …

Feat. D. Yang

22:33

Integrity CE

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

Feat. V. Lee, R. Kumar, N. Bhagat, E. Winslow

53:40

Philadelphia County Medical Society

Current Status for the Early Detection of Pancreatic Cancer

Feat. R. Brand

28:25

Integrity CE

Extensive, Liver-Only Metastases From Colon Cancer: Case Presentatio…

Feat. V. Lee, E. Christenson, N. Bhagat, E. Winslow

19:13

UChicago Medicine 12th International Clinical Cancer Genomics Conference

The Rising Tide of CRC in Younger Adults: Why Is This Happening &…

Feat. C. Eng

35:41

Dana-Farber Cancer Institute

Prevention of Esophageal Cancer: Screening and Surveillance

Feat. K. Jajoo

09:03

Integrity CE

Combined Hepatocellular-Cholangiocarcinoma: Diagnosis and Management

Feat. J. Birkness-Gartman

21:24

Icahn School of Medicine at Mount Sinai

Mount Sinai School of Medicine Colon Cancer Screening Updates

Feat. C. Cao

17:18

EAO-CRC Summit 2024

Advancements and Remaining Questions in Early-Age Onset CRC

Feat. C. Lieu

15:53

Yale Cancer Center

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Feat. A. Jaffe

32:58

Insights from 2024 ACP Annual Meeting

ACP 2024 Insights: Screening for Colorectal Cancer in Asymptomatic A…

Feat. T. J. Wilt

13:43

MedNews Week

Factors Driving Young Onset Colorectal Cancer

Feat. A. Khorana

26:48

Integrity CE

Locally Advanced High-Rectal Cancer: Case Presentation and Expert Pa…

Feat. V. Lee, R. Kumar, A. Gabre-Kidan, E. Christenson

19:57

Yale Cancer Center

Yale Cancer Center Updates on CRC Screening

Feat. S. Bogardus

17:54

Houston Methodist Hospital

AI in GI: Colon Cancer Screening and Beyond

Feat. R. Schiesser

Login

Login

Join VuMedi

ASCO® GI 2024 Insights: "Clinical Validation of Northstar Response, a Novel Methylated ctDNA Therapy Response Monitoring Assay in Patients With Advanced GI Cancer Undergoing Active Treatment"

Recommended